$80.00
In stock
| Quantity | Discount (%) | Price |
|---|---|---|
| 1 | — | $80.00 |
| 3 | 12.5 % | $70.00 |
| 6 | 18.75 % | $65.00 |
| 12+ | 25 % | $60.00 |
Free bacteriostatic water with every order.
Use our Research Peptide Storage Guide — Laboratory Use Only — to ensure proper handling and stability for controlled experimental applications. Not for human consumption, therapeutic, or diagnostic use.
Chemical Formula: C₁₆H₂₁N₃O₅
Molecular Weight: ~339.35 g/mol
CAS Number: 137388-70-2
Structure: Tripeptide derived from α-MSH with potent anti-inflammatory signaling activity
Form: Lyophilized powder
Solubility: Soluble in sterile water or aqueous buffers
Stability: Stable when frozen; limited stability after reconstitution
Half-Life: Short systemic half-life; rapidly metabolized in vivo
Storage: Store refrigerated at 36–46°F (2–8°C); protect from light and moisture
Reduces pro-inflammatory cytokine expression and dampens excessive inflammatory responses
Derived from α-MSH signaling pathways and influences immune-regulatory mechanisms
Supports balanced immune activation while limiting excessive inflammatory damage
Enhances epithelial integrity and protects mucosal tissues in research models
Investigated for decreasing inflammatory markers in gut and systemic tissue models
Studied for improving intestinal barrier function and reducing inflammatory bowel pathology markers
Explored for reducing inflammatory damage and supporting tissue healing responses
Evaluated for balancing immune signaling during acute and chronic inflammatory conditions
Studies demonstrate strong effects in intestinal inflammation models:
Reduces inflammatory markers in IBD models
Protects against epithelial barrier disruption
Improves mucosal healing and tissue regeneration
Enhances tripeptide uptake via PepT1 transport mechanisms
Research indicates measurable modulation of inflammatory pathways:
Decreases TNF-α and other pro-inflammatory cytokines
Reduces oxidative stress in tissue injury models
Supports immune-mediated inflammation control
Demonstrates protective effects in colitis and gut injury studies
Studies indicate KPV supports gut health beyond inflammation control:
Promotes beneficial gut microbiota balance in experimental colitis models
Enhances tight junction protein expression to strengthen epithelial barriers
Research suggests broader immune effects:
Reduces systemic inflammatory signaling in whole-organism models
Supports resolution of inflammation in multiple tissue injury contexts
KPV has demonstrated favorable tolerability in preclinical research
Few significant side effects reported at studied doses.
Possible mild, temporary irritation at administration sites.
Most safety data comes from animal and early-stage research models.
These effects appear to be dose-dependent and generally resolve after the peptide’s active period.
Independent laboratory testing confirms purity and composition
Purity
Batch
Date
